Thy1/CD90 Antibody (NT)

Thy1/CD90 Antibody (NT)is available at Gentaur for Next week Delivery.

Description: Thy1 is a GPI-anchored, developmentally regulated protein involved in various signaling cascades that mediate neurite outgrowth, T cell activation, tumor suppression, apoptosis, and fibrosis. It is highly expressed on the surface of adult neurons and is thought to play a role in modulating adhesive and migratory events, such as neurite extension. Decreased Thy1 expression is associated with the development of epithelial ovarian cancer, revealing its role as a putative tumor suppressor gene of human ovarian cancer. Thy1 knockout mice have impaired cutaneous immune responses and abnormal retinal development. Thy1 is epigenetically regulated or deregulated in some disease states, such as pulmonary fibrosis. The potentially reversible hypermethylation of the Thy1 promoter offers the possibility of novel therapeutic options in this disease.

Immunogen Sequence:This THY1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 36-65 amino acids from the N-terminal region of human THY1.

Target Alternative Name:THY1; Thy-1 membrane glycoprotein; CDw90; Thy-1 antigen; CD90

Species Reactivities:Human, Rat.

Tag Line:Polyclonal Antibody to detect Thy1/CD90 in human samples.

Formulation:In PBS with 0.09% (W/V) sodium azide.

Purification: This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.

Application:Western blot, IHC.

Positive Control:Western blot: T47D, HL60 cell lysate, IHC: human hepatocarcinoma and cancer tissue .

Application And Usages:WB: 1:1000, IHC: 1:50 – 1:100.

Handling:The antibody solution should be gently mixed before use.